Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
Het volume van chirurgische ingrepen en de impact ervan op ... - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
74 Volume Outcome <strong>KCE</strong> reports 113<br />
RELATION BETWEEN HOSPITAL VOLUME AND 2-YEAR MORTALITY<br />
RATE<br />
Table 5.27 shows the results analyses which were performed with the international cut<br />
29, 126<br />
off of 11 procedures per year (AHRQ and Leapfrog threshold).<br />
Table 5.27: Pancreatic cancer surgery: mortality per hospital based on<br />
international <strong>volume</strong> thresholds<br />
International cut<br />
off<br />
AHRQ cut<br />
off<br />
Hospital<br />
<strong>volume</strong><br />
category<br />
Number<br />
c<strong>en</strong>tres<br />
Number<br />
pati<strong>en</strong>ts<br />
3-months<br />
mortality<br />
Number<br />
<strong>de</strong>aths<br />
2-year<br />
mortality<br />
% Number<br />
<strong>de</strong>aths<br />
11/year 1-10/year 68 187 23 12.3 105 56.1<br />
≥11/year 5 114 11 9.6 55 48.2<br />
Table 5.28 shows results from the logistic regression mo<strong>de</strong>l (with GEE to adjust for<br />
clustering of pati<strong>en</strong>ts within hospitals) used to examine the relation betwe<strong>en</strong> hospital<br />
<strong>volume</strong> and 2-year mortality following peripancreatic cancer surgery.<br />
The first mo<strong>de</strong>l was performed without adjustm<strong>en</strong>t for case mix and suggest that the<br />
odd of 2 year mortality is 30% higher in hospitals with less than 11 interv<strong>en</strong>tions per<br />
year than in hospital with at least 11 interv<strong>en</strong>tions per year: odds ratio and 95% CI: 1.31<br />
(0.71, 2.42) This result did not reach statistical significance.<br />
In the second mo<strong>de</strong>l, an adjustm<strong>en</strong>t was ma<strong>de</strong> for pati<strong>en</strong>t characteristics which were<br />
retrieved from the MCD data i.e. sex, age, principal diagnosis and Charlson score. This<br />
adjustm<strong>en</strong>t does not affect the results of the <strong>volume</strong> effect (odss ratio and 95% CI 1.29<br />
(0.85, 1.94)) Pati<strong>en</strong>ts with a duod<strong>en</strong>um tumour have a higher mortality than those with<br />
a pancreas tumour, although not statistically significant (OR = 1.23, 95%CI 0.40-3.79).<br />
Pati<strong>en</strong>ts with a malignant ne<strong>op</strong>lasm of extrahepatic bile ducts or ampulla of Vater have a<br />
significant better survival rate than those with a malignant ne<strong>op</strong>lasm of pancreas (OR =<br />
0.37, 95%CI 0.20-0.69).<br />
The third mo<strong>de</strong>l also adjusted for tumour characteristics such as stage and histology of<br />
the peripancreatic cancer. This adjustm<strong>en</strong>t barely affects the effect of <strong>volume</strong>: OD and<br />
95% CI 1.25 (0.83, 1.89).<br />
%